Quantum-Si Inc reported the first quarter ended March 31, 2026 results: revenue $258,000, net income $21.7 million.
“For the first quarter of 2026, the Company recorded revenue of $258,000. Gross profit was $74,000 and gross margin was 29%. Total operating expenses were $24.1 million in the first quarter of 2026, compared to $25.6 million for the same period in the prior year. Adjusted total operating expenses were $21.4 million in the first quarter of 2026 compared to $22.9 million for the same period in the prior year.”
Todd Bennett was appointed as Chief Commercial Officer at Quantum-Si Inc.
“The Company has appointed Todd Bennett as the Company’s new Chief Commercial Officer, effective as of September 17, 2024.”
Grace Johnston resigned as Chief Commercial Officer at Quantum-Si Inc.
“On August 21, 2024, Grace Johnston, Ph.D. delivered her resignation as the Chief Commercial Officer of Quantum-Si Incorporated (the “Company”), effective as of September 6, 2024.”
Jonathan M. Rothberg changed role as Chairperson of the Board at Quantum-Si Inc.
“the Company’s current Chairperson of the Board, Jonathan M. Rothberg, Ph.D., continues to serve as a director of the Company but ceased serving as Chairperson of the Board.”
Charles Kummeth was appointed as Chairperson of the Board at Quantum-Si Inc.
“On May 27, 2024, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) elected Charles (“Chuck”) Kummeth to the Board and appointed him as Chairperson of the Board, each effective as of May 27, 2024”
Governance Changes
Quantum-Si Inc: Amended certificate of incorporation to remove director cap and add automatic conversion of Class B common stock on June 10, 2028 (effective 2024-05-16).
“On May 16, 2024, Quantum-Si Incorporated (the “Company”) filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to (i) remove the cap on the number of directors to serve on the Company’s board of directors (the “Board”) and make related changes to the process for filling newly created directorships or board vacancies (the “Director Cap Amendments”), and (ii) add a provision with respect to the automatic conversion of the Company’s Class B common stock effective June 10, 2028, which is seven years from the date of the closing of the business combination by and among Quantum-Si Incorporated (formerly HighCape Capital Acquisition Corp.), Tenet Merger Sub, Inc., and Q‐Si Operations Inc. (formerly Quantum-Si Incorporated) (the “Sunset Amendment” and together with the Director Cap Amendments, the “Charter Amendment”).”
Shareholder Votes
Quantum-Si Inc shareholders approved Sunset Amendment at the 2024-05-15 meeting.
“The Sunset Amendment was approved, based on the following votes: Class A Common Stock: Votes For Votes Against Votes Abstained Broker Non-Votes 61,429,495 254,661 80,694 - Class B Common Stock: Votes For Votes Against Votes Abstained Broker Non-Votes 398,750,000 - - -”
Shareholder Votes
Quantum-Si Inc shareholders approved Director Cap Amendments at the 2024-05-15 meeting.
“The Director Cap Amendments were approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 460,048,611 401,937 64,302 -”
Shareholder Votes
Quantum-Si Inc shareholders approved Advisory vote to approve named executive officer compensation at the 2024-05-15 meeting.
“The advisory vote of the compensation of the Company’s named executive officers, as described in the Proxy Statement, was approved, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 459,462,890 907,087 144,873 -”
Shareholder Votes
Quantum-Si Inc shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm at the 2024-05-15 meeting.
“The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, based on the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 460,397,267 71,110 46,473 -”
Earnings Releases
Quantum-Si Inc reported first quarter ended March 31, 2024 results: revenue $457,000, net income -$19.5 million (net loss of $19.5 million). Guidance reaffirmed.
“the “Company”), The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights ● Reported revenue of $457,000 in the first quarter of 2024 ● Commenced its full commercial launch of its Platinum ® instrument at the end of March 2024 ● On track to launch version 3 of its sequencing kit,”
Paula Dowdy was appointed as Director at Quantum-Si Inc.
“the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Paula Dowdy to the Board, effective as of March 21, 2024.”
Earnings Releases
Quantum-Si Inc reported the full year ended December 31, 2023 results: revenue $1.1 million, net income $96.0 million. Guidance initiated.
“For the full year ended December 31, 2023, the Company recorded revenue of $1.1 million, gross profit of $488,000, and gross margin of 45%. The periodic gross margin rate is expected to be variable in the near term as the Company works through the initial stages of commercialization as well as the timing and mix of product sales between instruments and consumable kits. Total operating expenses were $28.1 million in the fourth quarter of 2023, compared to $38.8 million for the same period in the prior year, and $111.7 million for the full year ended December 31, 2023, compared to $123.8 million for the same period in the prior year. Adjusted total operating expenses were $26.3 million in the fourth quarter of 2023, compared to $25.3 million for the same period in the prior year, and adjusted total operating expenses for the full year ended December 31, 2023, were $98.9 million compared to $103.2 million for the same period in the prior year. Overall adjusted operating expenses for 2023”
Earnings Releases
Quantum-Si Inc reported the fourth quarter ended December 31, 2023 results: revenue $400,000, net income $22.0 million. Guidance initiated.
“During the fourth quarter of 2023, the Company continued its controlled commercial launch of its Platinum instrument, recording revenue of $400,000. Gross profit was $178,000 and gross margin was 45%. For the full year ended December 31, 2023, the Company recorded revenue of $1.1 million, gross profit of $488,000, and gross margin of 45%. The periodic gross margin rate is expected to be variable in the near term as the Company works through the initial stages of commercialization as well as the timing and mix of product sales between instruments and consumable kits. Total operating expenses were $28.1 million in the fourth quarter of 2023, compared to $38.8 million for the same period in the prior year, and $111.7 million for the full year ended December 31, 2023, compared to $123.8 million for the same period in the prior year. Adjusted total operating expenses were $26.3 million in the fourth quarter of 2023, compared to $25.3 million for the same period in the prior year, and adjust”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.